Ireland
--:--IST
Priya Life Science Compound trial record
Compound · clinical trials

Nasopharyngeal swab clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 2 trials in our France register that name Nasopharyngeal swab as an intervention. Synced 12 Nov 2026
2Current trials
2Recruiting now
2Lead sponsors
1Country register
At a glance

Nasopharyngeal swab is named as an intervention in 2 current clinical trials in our France register. 2 are recruiting patients now. All registered phases are Not applicable. The sponsor with the most trials is Hospices Civils de Lyon (1). The most-studied condition is Nosocomial Infections.

Patient leaflets for Nasopharyngeal swab

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

  • UK
    United Kingdom: Search MHRA Products
    Patient information leaflets and SmPCs for UK-licensed products.
  • US
    United States: Search DailyMed
    FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

  • Recruiting2100%

Trials by phase

  • Not applicable2100%
01

Clinical trials of Nasopharyngeal swab

2 trials
StudyPhaseStatusLead sponsorRegisters
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
NCT05897879 · ClinicalTrials.gov ↗ · Bordetella Pertussis, Whooping Cough
Not applicable Recruiting Institut Pasteur France
Nosocomial Respiratory Virus Infection
NCT06643039 · ClinicalTrials.gov ↗ · Nosocomial Infections
Not applicable Recruiting Hospices Civils de Lyon France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Nasopharyngeal swab

2 conditions
Nosocomial Infections1Bordetella Pertussis, Whooping Cough1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Hospices Civils de Lyon1
Institut Pasteur1
04

By country register

RegisterTrialsRecruiting
Clinical trials in France22

A trial with sites in more than one country appears in each of those registers.

05

Related compounds

06

Questions about Nasopharyngeal swab trials

How many clinical trials are testing Nasopharyngeal swab?

2 current trials in our France register name Nasopharyngeal swab as a drug or biological intervention, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Nasopharyngeal swab trials recruiting patients?

Yes. 2 of the 2 trials are recruiting: 2 with sites in France. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Nasopharyngeal swab clinical trials?

Hospices Civils de Lyon (1) and Institut Pasteur (1). The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Nasopharyngeal swab works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Nasopharyngeal swab works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Nasopharyngeal swab (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.